Table 3 Unadjusted and multivariate analysis adjusted mean difference (95% CI) for sex hormones between baseline and 36 months per 1 kg weight loss.

From: Sex-differential testosterone response to long-term weight loss

Parameter

Univariate analysis

Multivariate analysisa

 

Trend estimate (kg/36 months; 95% CI)

Females

Testosterone

−0.8% (−1.4% to −0.3%)

−0.9% (−1.4% to −0.3%)

SHBG

0.5% (0.0% to 0.9%)

0.4% (−0.1% to 0.9%)

LH

0.8% (−0.1% to 1.6%)

−0.1% (−0.7% to 0.6%)

FSH

1.3% (0.3% to 2.3%)

0.1% (−0,6% to 0.7%)

Oestradiol

0.2% (−0.5% to 0.9%)

0.4% (−0.2 to 0.1%)

Males

Testosterone

0.6% (0.2% to 1.0%)

0.7% (0.3% to 1.1%)

SHBG

0.4% (0.0% to 0.8%)

0.4% (0.0% to 0.7%)

CFT

0.5% (0.0 to 0.9%)

0.7% (0.3% to 1.1%).

LH

0.2% (−0.2% to 0.6%)

0.1%(−0.5% to 0.3%)

FSH

0.5% (0.% to 1.0%)

0.6% (0.1% to 1.1%)

Oestradiol

0.1% (−0.3% to 0.5%)

0.2% (−0.1% to 0.6%)

All participants

ACTH

0.2% (−0.1% to 0.4%)

−0.3% (0% to −0.5%)

Cortisol

0.1% (−0.2% to 0.3%)

0.1% (−0.1% to 0.3%)

IGF1

0.4% (0.1% to 0.6%)

0.4% (0.2% to 0.7%)

TSH

0% (−0.4% to 0.5)

0.1% (−0.4% to 0.6%)

FT4

−0.2% (0 to −0.3%)

−0.2% (0% to −0.3%)

FT3

−0.1% (0% to −0.2%)

−0.1% (0% to −0.2%)

  1. Bolded values indicate statistical significance.
  2. ACTH adrenocorticotropic hormone, CFT calculated free testosterone, FSH Follicle-stimulating hormone, IGF1 insulin-like growth factor, LH Luteinizing hormone, SHBG sex hormone-binding globulin, TSH thyroid stimulating hormone, FT4 free thyroxine, FT3 free triiodothyronine.
  3. aAdjustment for the participants age (all patients) and menopausal status (females).